tiprankstipranks
Advertisement
Advertisement

MRVI Stock Latest News

Maravai Lifesciences announces opening of GMP enzyme manufacturing facility
The FlyMaravai Lifesciences announces opening of GMP enzyme manufacturing facility
14d ago
MRVI
Maravai LifeSciences Refinances Debt, Extends Credit Facilities
PremiumCompany Announcements
Maravai LifeSciences Refinances Debt, Extends Credit Facilities
27d ago
8K
MRVI
Maravai Lifesciences announces refinancing of credit agreement
PremiumThe Fly
Maravai Lifesciences announces refinancing of credit agreement
27d ago
MRVI
Maravai Lifesciences Shareholders Back Board, Pay, Auditor
PremiumCompany Announcements
Maravai Lifesciences Shareholders Back Board, Pay, Auditor
1M ago
8K
MRVI
Maravai Lifesciences Signals Turnaround in Earnings Call
PremiumCompany Announcements
Maravai Lifesciences Signals Turnaround in Earnings Call
2M ago
MRVI
Maravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank
PremiumThe FlyMaravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank
2M ago
MRVI
Maravai Lifesciences reports Q1 EPS 1c, consensus (5c)
Premium
The Fly
Maravai Lifesciences reports Q1 EPS 1c, consensus (5c)
2M ago
MRVI
Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $204.9M
Premium
The Fly
Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $204.9M
2M ago
MRVI
Maravai Lifesciences Charts Early Turnaround in 2025
PremiumCompany Announcements
Maravai Lifesciences Charts Early Turnaround in 2025
4M ago
MRVI
Maravai Lifesciences price target raised to $3 from $2 at Baird
PremiumThe Fly
Maravai Lifesciences price target raised to $3 from $2 at Baird
4M ago
MRVI
Balanced Risk/Reward Leads to Hold Rating as Restructuring Progress Offsets Ongoing Revenue Pressures
PremiumRatings
Balanced Risk/Reward Leads to Hold Rating as Restructuring Progress Offsets Ongoing Revenue Pressures
4M ago
MRVI
Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)
PremiumThe Fly
Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)
4M ago
MRVI
Maravai Lifesciences sees FY26 revenue $200M-$210M, consensus $203.26M
PremiumThe FlyMaravai Lifesciences sees FY26 revenue $200M-$210M, consensus $203.26M
4M ago
MRVI
MRVI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MRVI Earnings this Week: How Will it Perform?
4M ago
MRVI
Maravai Lifesciences price target raised to $4.50 from $4 at Wells Fargo
Premium
The Fly
Maravai Lifesciences price target raised to $4.50 from $4 at Wells Fargo
7M ago
MRVI
Maravai Lifesciences director buys $368.5K in common stock
PremiumThe Fly
Maravai Lifesciences director buys $368.5K in common stock
7M ago
MRVI
Closing Bell Movers: Inotiv surges after quarterly results
PremiumThe Fly
Closing Bell Movers: Inotiv surges after quarterly results
7M ago
APYX
AXTA
Maravai Lifesciences CEO buys $702.7K of class A shares
PremiumThe Fly
Maravai Lifesciences CEO buys $702.7K of class A shares
7M ago
MRVI
Maravai LifeSciences Earnings Call: Mixed Signals
PremiumCompany Announcements
Maravai LifeSciences Earnings Call: Mixed Signals
8M ago
MRVI
Maravai Lifesciences price target lowered to $4 from $5 at Stifel
PremiumThe FlyMaravai Lifesciences price target lowered to $4 from $5 at Stifel
8M ago
MRVI
Cautious Optimism for Maravai Lifesciences: Hold Rating Amidst Strategic Recovery Efforts
Premium
Ratings
Cautious Optimism for Maravai Lifesciences: Hold Rating Amidst Strategic Recovery Efforts
8M ago
MRVI
Maravai LifeSciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Maravai LifeSciences Reports Q3 2025 Financial Results
8M ago
MRVI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >